Nanotech-based delivery technologies are receiving significant attention

Overcoming the Poor Solubility of Cannabinoids

Smart tools used in early drug discovery can have an impact on downstream phases of drug development.

Using Smart Tools for Smart Development

Obstacles remain before broader application of intensified processes can be implemented.

Formulating Drugs for Continuous Processing

Topic

Feliza Mirasol is the science editor for 

Articles

Under the collaboration, Orionis will receive $47 million upfront to leverage its Allo-Glue platform to discover small-molecule monovalent glues.

Genentech Partners with Orionis Biosciences to Discover and Develop Molecular Glue Class Medicines

Webcasts

Webinar Date/Time: Wed, Oct 4, 2023 - 11:00 am EDT | 4:00 pm GMT | 5:00 pm CEST | 8:00 am PDT

High Performance Solutions for Dpi Delivery: New Formulation and Device Platforms

Webinar Date/Time: Wed, Oct 11, 2023 - 11:00 am EDT | 4:00 pm GMT | 5:00 pm CEST | 8:00 am PDT

Accessing Continuous Tableting Through a CDMO

The EMA’s Committee for Medicinal Products for Human Use has given a positive opinion on Sandoz’ biosimilar trastuzumab for breast and gastric cancer.

EMA Committee Issues Positive Opinion on Sandoz’ Biosimilar Trastuzumab

Recipharm will provide analytical and process development capabilities to support toxicology studies, in addition to GLP manufacturing of lipid nanoparticles to capture the active pharmaceutical ingredient, an antigen peptide. 

Recipharm Partners with Ahead Therapeutics to Develop Rare Autoimmune Disease Therapy 

The agreement states that Orbit will implement its bead-based peptide display engine to discover peptide leads specific to targets related to specific tumors.

Orano Med and Orbit Discovery Enter Collaboration for New Novel Targeted Radioligand Therapies 

Advanced analytical tools generate more data in today’s labs than ever before.

Dealing with Data: How to Keep It Manageable

Podcasts

Drug Solutions Podcast: Breaking Through the Barriers of Drug Development

Webinar Date/Time: Wed, Oct 11, 2023 11:00 AM EDT 

A bioanalytical discovery strategy for fast and flexible decision making

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

Excipients should be treated equally when it comes to quality management, risk assessment, and testing.